image: This image shows human regulatory T cells (green) interacting with immune antigen presenting cells (red) of human skin transplants performed in the humanized mouse, allowing the in vivo study of the biology and function of Treg therapy in preparation for clinical use. This image relates to a paper that appeared in the May 18, 2011, issue of Science Translational Medicine, published by AAAS. The paper, by Dr. Pervinder Sagoo of King's College in London, UK, and colleagues, was titled, "Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells." view more
Credit: Image courtesy of Dr. Pervinder Sagoo